Plasma LCN2 is known as a biomarker of acute kidney injury, arthritis, acute pancreatitis, obesity, cardiovascular disease, and multiple sclerosis [28]. This evidence concerns the gene LCN2 and obesity due to melanocortin 4 receptor deficiency.